Bernier S G, Servant G, Boudreau M, Fournier A, Guillemette G
Department of Pharmacology, Faculty of Medicine, University of Sherbrooke, Québec, Canada.
Eur J Pharmacol. 1995 Oct 15;291(2):191-200. doi: 10.1016/0922-4106(95)90142-6.
We have characterized a specific binding site for angiotensin IV on bovine aortic endothelial cell membranes. Pseudo-equilibrium studies at 37 degrees C for 2 h have shown that this binding site recognizes angiotensin IV with a high affinity (Kd = 0.71; average of two experiments that yielded values of 0.71 and 0.72 nM). The binding site is saturable and relatively abundant with a maximal binding capacity of 0.59 pmol/mg protein (average of two experiments that yielded values of 0.39 and 0.78 pmol/mg of protein). Non-equilibrium kinetic analyses at 37 degree C revealed a calculated Kd of 59 pM (average of two experiments that yielded values of 67 and 50 pM). The binding site displays a high affinity for angiotensin receptors AT1 or AT2. An analysis of specificity showed that the binding site displays a high affinity for angiotensin IV, low affinities for angiotensin II, [Sar1, Val5, Ala8]angiotensin II and does not recognize L-158,809 (5,7-dimethyl-2-ethyl-3-[(2'-(1 H-tetrazole-5-yl)[1,1'-biphenyl]-4-yl)methyl]-3H-imidazo[4, 5-beta]pyridine H2O) and PD 123319 (1-[4-dimethylamino)3-methylphenyl]methyl-5-(diphenylacetyl) 4,5,6,7-tetrahydro-1 H-imidazo[4,5-c]pyridine-6-carboxylic acid). A few unrelated hormones (bradykinin, [Arg8] vasopressin, endothelin-1, atrial natriuretic factor, isoproterenol and adrenocorticotropic hormone) were unable to inhibit any 125I-angiotensin IV binding. The affinities of different structural analogues of angiotensin IV revealed that the N-terminal position is critical for receptor recognition and the C-terminal proline is also important. GTP gamma S and polyvinyl sulfate did not affect the binding, suggesting that the receptor is not coupled to a G-protein. The divalent cations Mg2+ and Ca2+ were shown to diminish the binding of 125I-angiotensin IV. Cross-linking of 125I-angiotensin IV to bovine aortic endothelial cell membranes in the presence of disuccinimidyl suberate, followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) revealed a major band of 186 +/- 12 kDa. The presence in high concentration of this angiotensin binding site on aortic endothelial cells suggest the existence of a novel mechanism involved in the control of vascular tone or vascular permeability.
我们已对牛主动脉内皮细胞膜上血管紧张素IV的特异性结合位点进行了表征。在37℃下进行2小时的准平衡研究表明,该结合位点以高亲和力识别血管紧张素IV(解离常数Kd = 0.71;两次实验的平均值,分别得到0.71和0.72 nM的值)。该结合位点具有饱和性且相对丰富,最大结合容量为0.59 pmol/mg蛋白质(两次实验的平均值,分别得到0.39和0.78 pmol/mg蛋白质的值)。在37℃下进行的非平衡动力学分析显示,计算得到的Kd为59 pM(两次实验的平均值,分别得到67和50 pM的值)。该结合位点对血管紧张素受体AT1或AT2具有高亲和力。特异性分析表明,该结合位点对血管紧张素IV具有高亲和力,对血管紧张素II、[Sar1, Val5, Ala8]血管紧张素II具有低亲和力,且不识别L-158,809(5,7-二甲基-2-乙基-3-[(2'-(1H-四氮唑-5-基)[1,1'-联苯]-4-基)甲基]-3H-咪唑并[4,5-β]吡啶水合物)和PD 123319(1-[4-(二甲基氨基)3-甲基苯基]甲基-5-(二苯基乙酰基)4,5,6,7-四氢-1H-咪唑并[4,5-c]吡啶-6-羧酸)。一些不相关的激素(缓激肽、[Arg8]加压素、内皮素-1、心房利钠因子、异丙肾上腺素和促肾上腺皮质激素)无法抑制任何125I-血管紧张素IV的结合。血管紧张素IV不同结构类似物的亲和力表明,N端位置对受体识别至关重要,C端脯氨酸也很重要。鸟苷三磷酸γ-硫酯(GTPγS)和聚硫酸乙烯酯不影响结合,表明该受体不与G蛋白偶联。已证明二价阳离子Mg2+和Ca2+会减少125I-血管紧张素IV的结合。在辛二酸二琥珀酰亚胺酯存在下,将12I-血管紧张素IV与牛主动脉内皮细胞膜交联,然后进行十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE),显示出一条主要条带,分子量为186±12 kDa。主动脉内皮细胞上高浓度存在这种血管紧张素结合位点,提示存在一种参与血管张力或血管通透性控制的新机制。